Conclusion

  • Although the presentations of CSCR can be quite typical, it is important to rule out infectious and inflammatory etiologies, including white dot syndrome, for appropriate management in patients who present atypically.
  • In the absence of active central serous chorioretinopathy, careful observation with periodic eye exams is appropriate with patient education on use of Amsler grid for self-monitoring of their vision.
  • Photodynamic therapy or subthreshold micropulse laser can be considered in cases of active and non-resolving central serous chorioretinopathy. Although some small studies have been performed on other treatment types such as transpupillary thermal therapy, intravitreal injections and oral pharmacologics, larger studies have to be done to determine how to best incorporate these practices, if at all.
  • There may not be a consensus on the best first-line treatment but it is agreed upon that treatment is indicated in patients who present with chronic CSCR and the goal of treatment should be to achieve complete resolution of the serous retinal detachment, as even a small amount of remaining subretinal fluid can lead to irreversible damage to the photoreceptors.